Daily Oncology News
Adverse reactions to St. John's Wort were similar to those reported for fluoxetine.
There is no clinically relevant evidence of an association between opioid prescriptions and breast cancer recurrence.
Adults in the LGBTQ community tend to be lower economic status and seek health care less often.
Addition of omega-3 fatty acids to anti-cancer medications may improve quality of life and treatment outcomes in patients with cancer.
ASCO has called on the U.S. government and the cancer research community to broaden clinical trials to include older adults.
Breast cancer survivors who experience pain or discomfort during sexual intercourse may benefit from applying liquid lidocaine to the vulvar area.
Many young patients with cancer may have limited knowledge of fertility preservation options.
Chemotherapy administered to patients with cancer who are near death does not improve quality of life.
More evidence that two classes of generic drugs (aromatase inhibitors and bisphosphonates) reduce the risk of death in early breast cancer.
Patients with prostate cancer are now more likely to receive medical care matched to risk level.
Industry Supported Education
- In breast cancer survivors, lidocaine may relieve pain during intercourse
- Likelihood of lung cancer screening update
- Generic meds may boost survival in some early breast cancers
- Aromatase inhibitors substantially reduce risk of death in ER-positive breast cancer
- Activated T cell therapy developed for advanced melanoma
- St. John's wort: natural does not necessarily mean safe
- No association between opioids, breast cancer recurrence
- Researchers, providers need to address cancer health care disparities in LGBTQ community
- New combination could make cancer more sensitive to chemotherapy
- New approach to treating B-cell acute lymphoblastic leukemia shows promise
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|